
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-498-5710
Dr. Jump is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford University School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 1997 - 2027
- HI State Medical License 1997 - 1997
Publications & Presentations
PubMed
- 13 citationsRisk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.W Ray Kim, Laura E Telep, Belinda Jump, Mei Lu, Heribert Ramroth
Alimentary Pharmacology & Therapeutics. 2022-04-01 - 10 citationsTreatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retr...Pietro Lampertico, Thomas Berg, Maria Buti, Anita Pathil, Joerg Petersen
Alimentary Pharmacology & Therapeutics. 2020-06-25 - 92 citationsTen-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infectionPatrick Marcellin, David Wong, William Sievert, Peter Buggisch, Jörg Petersen
Liver International. 2019-10-01
Journal Articles
- Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate plus Peginterferon Alfa-2a: Week 120 AnalysisBelinda Jump, Xiaoli Ma, Digestive Diseases and Sciences
- Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate plus Peginterferon Alfa-2a: Week 120 AnalysisXiaoli Ma, Belinda Jump, Digestive Diseases and Sciences
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: